Nigel R. A. Beeley
Plus aucun poste en cours
Profil
Nigel R.A.
Beeley joined Senomyx, Inc. as Vice President of Discovery in June 2004.
From March 1999 to June 2004, Dr. Beeley was Vice President and Chief Chemical Officer of Arena Pharmaceuticals, Inc. From 1994 to 1998, he was Senior Director of Chemistry for Amylin Pharmaceuticals, Inc. From 1988 to 1994, Dr. Beeley was Head of Oncology and Chemistry for Celltech.
From 1980 to 1988, he held various positions in the cardiovascular group at Synthelabo Research.
From 1978 to 1980, Dr. Beeley was a CNS Medicinal Chemist of the Pharmaceutical Division for Reckitt and Coleman.
From 1976 to 1978, he was a Royal Society Overseas Research Fellow of ETH in Zurich, Switzerland.
He received a BSc degree in Chemistry from the University of Liverpool and a PhD degree in Chemistry from the University of Manchester.
Anciens postes connus de Nigel R. A. Beeley
| Sociétés | Poste | Fin |
|---|---|---|
| ARENA PHARMACEUTICALS | Corporate Officer/Principal | 01/06/2004 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/1998 |
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Corporate Officer/Principal | 01/01/1994 |
| SENOMYX INC. | Corporate Officer/Principal | - |
Formation de Nigel R. A. Beeley
| The University of Liverpool | Undergraduate Degree |
| The University of Manchester | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Senomyx, Inc.
 Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Senomyx, Inc. engages in the development and commercialization of flavor ingredients for the packaged food, beverage, and ingredient supply industries. It develops high intensity sweeteners, savory flavors, bitter taste blockers, and cooling agents. The company was founded by Paul A. Grayson, Lubert Stryer, Yon Chien Tsien, Denis Baylor, Harold McGee, and Charles Zuker on September 16, 1998 and is headquartered in San Diego, CA. | Consumer Non-Durables |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Health Technology |
